Lv41
564 积分 2024-09-18 加入
FGF4 protects the liver from nonalcoholic fatty liver disease by activating the AMP‐activated protein kinase–Caspase 6 signal axis
25天前
已完结
Influence of Kazachstania spp. on the chemical and sensory profile of red wines
1个月前
已完结
Kazachstania humilis
1个月前
已完结
Isolating lipid droplets from multiple species
1个月前
已完结
Hepatic sphingomyelin phosphodiesterase 3 promotes steatohepatitis by disrupting membrane sphingolipid metabolism
1个月前
已完结
EHBP1 suppresses liver fibrosis in metabolic dysfunction-associated steatohepatitis
2个月前
已完结
Farnesyl diphosphate synthase exacerbates nonalcoholic steatohepatitis via the activation of AHR‐CD36 axis
2个月前
已完结
Current status and future perspectives of FGF21 analogues in clinical trials
2个月前
已完结
The therapeutic potential of FGF21 in metabolic diseases: from bench to clinic
2个月前
已完结
A researcher’s guide to preclinical mouse NASH models
2个月前
已完结
皖公网安备34019202002308
